Birchview Capital, LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Birchview Capital, LP held in its portfolio 68 assets valued at $170,798,560 (i.e. $170.80M).
The most valuable assets in the portfolio included: KLA CORPORATION ($26.59M), BRISTOL-MYERS SQUIBB CO ($16.34M), and COMPASS THERAPEUTICS INC ($8.55M).
The chart below shows the top 10 valuable assets, and the table below shows the top 68 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Birchview Capital, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| KLA CORPORATION | 21883 | 26589596 | COM NEW |
| BRISTOL-MYERS SQUIBB CO | 302842 | 16335297 | COM |
| COMPASS THERAPEUTICS INC | 1592938 | 8554077 | COM |
| STOKE THERAPEUTICS INC | 260000 | 8252400 | COM |
| LAM RESEARCH CORPORATION | 40329 | 6903518 | COM NEW |
| OLEMA PHARMACEUTICALS INC | 269000 | 6725000 | COM |
| STRUCTURE THERAPEUTICS INC | 90000 | 6259500 | SPONS ADR |
| PROTAGONIST THERAPEUTICS INC | 55000 | 4803700 | COM |
| ACADIA PHARMACEUTICALS INC | 171000 | 4567410 | COM |
| OVINTIV INC | 107500 | 4212925 | COM |
| PROTHENA CORP PLC | 441019 | 4211731 | SHS |
| SOLID BIOSCIENCES INC | 705955 | 3981586 | COM NEW |
| NEUROCRINE BIOSCIENCES INC | 27190 | 3856358 | COM |
| AMICUS THERAPEUTICS INC | 253000 | 3602720 | COM |
| BICYCLE THERAPEUTICS PLC | 462700 | 3275916 | SPONSORED ADS |
| PHATHOM PHARMACEUTICALS INC | 195000 | 3235050 | COM |
| CASTLE BIOSCIENCES INC | 80600 | 3135340 | COM |
| INTELLIA THERAPEUTICS INC | 315400 | 2835446 | COM |
| IMMUNOME INC | 130000 | 2792400 | COM |
| CORCEPT THERAPEUTICS INC | 67200 | 2338560 | COM |
| VERA THERAPEUTICS INC | 44000 | 2228160 | CL A |
| QUIDELORTHO CORP | 72548 | 2071971 | COM |
| NOVOCURE LTD | 152100 | 1966653 | ORD SHS |
| BIODESIX INC | 286804 | 1950267 | COM |
| CYTOKINETICS INC | 30000 | 1906200 | COM |
| PHREESIA INC | 110700 | 1873044 | COM |
| EQT CORPORATION | 34619 | 1855578 | COM |
| HARROW HEALTH INC | 34000 | 1666000 | COM |
| TRAVERE THERAPEUTICS INC | 43000 | 1643030 | COM |
| FOGHORN THERAPEUTICS INC | 281730 | 1521342 | COM |
| UNITED THERAPEUTICS CORP | 3000 | 1461750 | COM |
| ULTRAGENYX PHARMACEUTICAL INC | 62000 | 1426000 | COM |
| ALKERMES PLC | 50000 | 1399000 | SHS |
| NEKTAR THERAPEUTICS | 31000 | 1310680 | COM |
| APOGEE THERAPEUTICS INC | 16000 | 1207680 | COM |
| VERASTEM INC | 150000 | 1158000 | COM NEW |
| AXSOME THERAPEUTICS INC | 6061 | 1106981 | COM |
| MASIMO CORP | 8280 | 1076897 | COM |
| 10X GENOMICS INC | 59000 | 962290 | COM |
| XENON PHARMACEUTICALS INC | 21000 | 941220 | COM |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | 500000 | 935000 | COM |
| KALVISTA PHARMACEUTICALS INC | 57000 | 920550 | COM |
| FREEPORT-MCMORAN CL-B | 18046 | 916577 | CL-B |
| VENTYX BIOSCIENCES INC | 100827 | 910468 | COM |
| PHARVARIS N V | 29847 | 828254 | COM |
| ILLUMINA INC | 6000 | 786960 | COM |
| UNIQURE NV | 30789 | 736781 | SHS |
| HALOZYME THERAPEUTICS INC | 10100 | 679730 | COM |
| BIOHAVEN LTD | 59365 | 670231 | COM |
| BRIDGEBIO PHARMA INC | 8688 | 664545 | COM |
| TREACE MEDICAL CONCEPTS INC | 226947 | 556020 | COM |
| PULMONX CORP | 250573 | 553766 | COM |
| RAPT THERAPEUTICS INC | 15000 | 508050 | COM NEW |
| GOSSAMER BIO INC | 138176 | 428346 | COM |
| ALPHATEC HOLDINGS INC | 18058 | 379940 | COM |
| OUTSET MEDICAL INC | 98913 | 366967 | COM |
| APELLIS PHARMACEUTICALS INC | 14000 | 351680 | COM |
| LIQUIDIA TECHNOLOGIES INC | 10000 | 344900 | COM |
| CANDEL THERAPEUTICS INC | 60000 | 339000 | COM |
| VOYAGER THERAPEUTICS INC | 74918 | 294428 | COM |
| TRINITY CAP INC | 20000 | 293000 | COM |
| INHIBRX BIOSCIENCES INC | 3698 | 292142 | COM |
| KAYNE ANDERSON BDC INC | 20000 | 286400 | COM SHS |
| CULLINAN THERAPEUTICS INC | 20000 | 207000 | COM |
| ELUTIA INC | 263018 | 182193 | COM |
| ALUMIS INC | 10000 | 97600 | COM |
| DOCGO INC | 49908 | 43809 | COM |
| ZENTALIS PHARMACEUTICALS INC | 17000 | 22950 | COM |